The development and implementation of highly multiplex molecular diagnostic tests have allowed clinical microbiology laboratories to more rapidly and sensitively detect a variety of pathogens directly in clinical specimens. The industry with new molecular diagnostic (MDx) tests is significantly less costly, while simultaneously increasing the number of targets per test through high multiplexing. The advanced technology has the potential to drive growth in the market, particularly in areas such as infectious disease testing, genetic analysis, and personalized medicine. Validation of a large number of disease markers in both molecular and protein diagnostics has paved the way for the emergence of the multiplex assay. The simple low-throughput multiplex assays followed by low-level multiplexing and high-throughput array-based immunoassays are replaced with two types of high-level multiplexing and high-throughput diagnostic methods using microspot arrays and bead arrays. Benefits of using multiplex molecular diagnostics array platforms include improved-quality patient care, as well as cost effectiveness and time saving.
The global multiplex molecular diagnostics market segmentation is based on technology (low density assays – quantitative PCR, microplate assays, medium density assays – bead-based arrays, antibody arrays, reverse arrays, mass spectrometry, high density assays – bacterial artificial chromosome arrays, protein arrays, very high density assays – oligonucleotide arrays, second generation sequencing, phage display), application (allergies, autoimmune diseases, cardiac diseases, infectious disease diagnostic, oncology, pregnancy & fertility testing), end users (academic research institutes, clinical research organizations, diagnostic laboratories, hospital, pharmaceutical companies).
The global multiplex molecular diagnostics market report provides market size (Revenue US$ Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global multiplex molecular diagnostics market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global multiplex molecular diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.
Major players operating in the global multiplex molecular diagnostics market and profiled in this report include Abbott Laboratories, Agilent Technologies, bioMérieux SA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Illumina, Inc., Luminex Corporation, Siemens Healthineers, and Thermo Fisher Scientific, Inc.